The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era
Mohanad Al‐Obaidi, Ahmet B. Gungor, Sangeetha Murugapandian, Bijin Thajudeen, Iyad Mansour, Ryan C. Wong, Bekir Tanrıöver, Tirdad T. Zangeneh
Topics & Concepts
MedicineInterquartile rangeConfidence intervalCoronavirus disease 2019 (COVID-19)Internal medicinePropensity score matchingRitonavirSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Retrospective cohort studyDiseaseImmunologyViral loadVirusInfectious disease (medical specialty)Antiretroviral therapySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and Effects